The biotech's stock ... a COVID-19 vaccine that is currently its only product on the market. The company has been working on two other candidates. One is an investigational influenza vaccine.
Novavax Inc.’s stock tumbled 19% early Wednesday ... has placed a clinical hold on its COVID-19-and-flu combination and stand-alone flu vaccine candidates, following a case of motor neuropathy ...
(RTTNews) - Novavax, Inc. (NVAX) Monday said the Food and Drug Administration or FDA has removed the clinical hold on its COVID-19-Influenza Combination (CIC) and stand-alone influenza vaccine ...
ABC News on MSN22d
Bird flu cases rise to 31 in US, still no evidence of person-to-person spread: CDCThe number of bird flu cases has risen to 31 in the U.S. but there is no evidence of person-to-person transmission, the CDC said in a press conference on Thursday.
Move comes after a single participant in a mid-stage trial reported a case of motor neuropathy Novavax Inc.'s stock tumbled ... COVID-19-and-flu combination and stand-alone flu vaccine candidates ...
The clinical hold has been placed on the company’s Investigational New Drug applications for the vaccines. Novavax’s stock slides 16% after FDA puts clinical hold on COVID and flu vaccine cand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback